Biopharmas raising money in public or private financings, including: Adamis, Aptevo, Aridis, CG Oncology, Cyclo, Forte, Inozyme, Reglagene, Tarsus, Tonix.

New hires and promotions in the biopharma industry, including: Akari, Catalent, Catena, Jasper, Omass, Purespring.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Bigomics, Bio-Gate, Bodyport, Caredx, Click Therapeutics, Concertai, Dnanexus, Guardant, Gynesonics, Immprev Bio, Karius, Syneos Health, Terarecon.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Alucent, Sonio.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: ADC, Beigene, Biocon, Daiichi Sankyo, GC, Hanchorbio, Hansoh, Incannex, Innocare, Jiangsu Recbio, Mabwell, Opthea, Overland, Scynexis, Sinopharm, SN.

Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief: Amarin, Astellas, Lotus, Peptidream.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Alterity, Ascletis, Astrazeneca, Daiichi Sankyo, Essex, Immuron, Immutep, Pharmabcine, Recce, Remegen, Sunho, Takeda, Triastek.

Biopharmas in Asia-Pacific raising money in public or private financings: Adlai Nortye, Immuno Cure.

New hires and promotions in the biopharma industry in Asia-Pacific, including: Hangzhou Qihan.